The biggest buzz in skincare right now is topical injectibles, aka topical Botox. Allergan (who owns Botox) is spending $90 million up front, and promising undisclosed future cash for Anterios, a New York City biotech at work on technology that could allow neurotoxins to be delivered through the skin without the need for needles. Having had…
You must be logged in to post a comment.